INS and pancreatic insulinoma: The diminished insulin and C-peptide levels, together with the patient's medication history and the lack of pertinent autoimmunity, ruled out insulinoma, factitious hypoglycemia from exogenous insulin or sulfonylureas, autoimmune hypoglycemia, and adrenal insufficiency.